News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dhingra Ankur
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/08/2023 |
4
| Dhingra Ankur (CFO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 196,362 shares
@ $1.05, valued at
$206.2k
|
|
| 03/08/2023 |
4/A
| Dhingra Ankur (CFO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 13,027 shares
@ $0.97, valued at
$12.6k
Bought 24,658 shares
@ $0.97, valued at
$23.9k
|
|
| 08/17/2022 |
4
| Dhingra Ankur (CFO) has filed a Form 4 on Summit Therapeutics Inc.|
Txns:
| Bought 11,557 shares
@ $0.97, valued at
$11.2k
Bought 24,658 shares
@ $0.97, valued at
$23.9k
|
|
| 06/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Dhingra Ankur (CFO) has filed a Form 4 on CareDx, Inc.|
Txns:
| Granted 19,900 shares
@ $0
Granted 34,900 options to buy
@ $41.32, valued at
$1.4M
|
|
| 11/29/2021 |
4
| Dhingra Ankur (CFO) has filed a Form 4 on CareDx, Inc.|
Txns:
| Bought 5,000 shares
@ $42.3387, valued at
$211.7k
|
|
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|